{
  "id": "14f4ee694d5811ba",
  "title": "FinancialContent - Travere Therapeutics Shares Fall After FDA Extends Filspari Review for FSGS",
  "description": "20260113T230000Z",
  "content": "",
  "source": "markets.financialcontent.com",
  "source_url": "https://markets.financialcontent.com/stocks/article/marketminute-2026-1-13-travere-therapeutics-shares-fall-after-fda-extends-filspari-review-for-fsgs",
  "published_at": "20260113T230000Z",
  "fetched_at": "2026-01-14T00:24:05.619157+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://markets.financialcontent.com/stocks/article/marketminute-2026-1-13-travere-therapeutics-shares-fall-after-fda-extends-filspari-review-for-fsgs",
    "url_mobile": "",
    "title": "FinancialContent - Travere Therapeutics Shares Fall After FDA Extends Filspari Review for FSGS",
    "seendate": "20260113T230000Z",
    "socialimage": "https://marketminute.ghost.io/content/images/size/w1200/2026/01/210df25e-1bbb-457e-8bbd-1bc1fe26257f.png",
    "domain": "markets.financialcontent.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}